Vaccines Market Overview by Influenza, Hepatitis and Dengue Disease and Projected to Reach US$ 50.42 Billion by 2023

20 August, 2018

Study estimates the vaccines market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report.

Download Latest Brochure of Vaccines Market spread across 184 Pages, Profiling 15 Companies and Supported with 93 Tables and 46 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=110437 .

Prominent players in the vaccines market include Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (US), GlaxoSmithKline, plc (UK), Johnson & Johnson (US), MedImmune, LLC (US), Merck & Co., Inc. (US), Pfizer, Inc. (US), Sanofi Pasteur SA (France), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Biological E (India), and Panacea Biotec (India).

Vaccines Market, By Technology
• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines

Vaccines Market, By Disease Indication
• Pneumococcal Disease
• Influenza
• DTP
• Hepatitis
• Human Papilloma Virus (HPV)
• Rotavirus
• Meningococcal Disease
• MMR (measles, mumps, and rubella)
• Varicella
• Polio
• Herpes Zoster
• Dengue

Click Here For More Information on Vaccines Market Top Trends and Company Profiles at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=110437 .

The vaccines market is segmented into pneumococcal disease, influenza, DTP, hepatitis, human papillomavirus (HPV), rotavirus, meningococcal disease, MMR (measles, mumps, and rubella), varicella, polio, herpes zoster, dengue, and other disease indications. The meningococcal disease segment is expected to witness the highest growth during the forecast period.

Target Audience for this Report:
• Manufacturers and suppliers of vaccines
• Research and development companies
• Medical research laboratories
• Academic medical centers and universities
• Research and consulting firms
• Venture capital firms

The growth of this segment is primarily attributed to high incidence of meningococcal disease and increasing government investments in meningococcal vaccination programs. Based on route of administration, the vaccines market is segmented into intramuscular and subcutaneous administration, oral administration, and other routes of administration.

Information and Discount on this study “Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023” research at http://www.rnrmarketresearch.com/contacts/discount?rname=110437 .

The vaccines market is segmented into pediatrics and adults. Adult segment is expected to register highest CAGR during forecast period. Factors like increasing investments by companies for development of new adult vaccines and government initiatives for immunization are driving the growth of this segment.

The objectives of this study are as follows:
• To define, describe, and forecast the vaccines market by technology, type, disease indication, route of administration, patient type, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, restraints, and industry-specific challenges)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
• To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
• To track and analyze competitive developments such as mergers and acquisitions, product developments, partnerships, agreements and collaborations, expansions, and R&D activities in the vaccines market.

Start Publishing

ReportsnReports


More related article